Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast.

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

The pharmaceutical company says it will continue to operate its production facility near Research Triangle Park.

North Carolina-based biotech Tune Therapeutics has raised $175 million in a Series B that will help it to take its lead epigenetic silencing drug, Tune-401, into clinical testing as a potential ...

The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Meet the changemakers redefining healthcare in India through innovation, compassion, and purpose-driven leadership. From ...

In a major announcement for the world of digital entertainment and social gaming, WOW Vegas has confirmed the extension of its partnership with global entrepreneur, media personality, and pop culture ...

Freenome, a biotechnology company pioneering an early cancer detection platform, today announced the appointment of Aaron Elliott, Ph.D., as its new chief executive officer. With nearly 20 years in ...

The COVID-19 pandemic brought unprecedented challenges to global health systems and economies, highlighting significant gaps ...

JBL is set to launch Tune Series 2 in India with ANC, 48-hour battery, and app control starting at ₹5XX9 this month.

JBL expands its Tune Series 2 product line in India, introducing three new styles of earbuds – Buds 2, Beam 2, and Flex 2.